Improvement in right lung atelectasis (middle lobe syndrome) following administration of low-dose roxithromycin

Masahide Kawamura, Yasumichi Arai, Masato Tani

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Middle lobe syndrome is a distinct clinical entity characterized by right middle lobe atelectasis. Prompt diagnosis and initiation of medical therapy including the administration of antibiotics and the avoidance of irritating agents may be effective. However, abnormal shadows on chest radiography remain unchanged even when acute symptoms have disappeared, suggesting latent lesional inflammation or recurrence. We describe 2 cases of atelectasis in the middle lobe of the right lung which resolved completely after administration of low-dose roxithromycin. Thus, low-dose therapy with a macrolide could be of interest or some value in these cases, but it is too early to draw a definite conclusion.

Original languageEnglish
Pages (from-to)210-214
Number of pages5
JournalRespiration
Volume68
Issue number2
DOIs
Publication statusPublished - 2001 Apr 12

Keywords

  • Atelectasis
  • Macrolide
  • Middle lobe syndrome

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'Improvement in right lung atelectasis (middle lobe syndrome) following administration of low-dose roxithromycin'. Together they form a unique fingerprint.

  • Cite this